The Crafty Opponent: the Defense Systems of Staphylococcus Aureus and Response Measures

Overview

Journal Folia Microbiol (Praha)

Publisher Springer

Specialty Microbiology

Date 2022 Feb 12

PMID 35149955

Authors

Hongjie Hou

Yang Li

Yuefei Jin

Shuaiyin Chen

Jinzhao Long

Guangcai Duan

Haiyan Yang

Affiliations

Soon will be listed here.

Abstract

Staphylococcus aureus is a serious threat to public health. S. aureus infection can cause acute or long-term persistent infections that are often resistant to antibiotics and are associated with high morbidity and death. Understanding the defensive systems of S. aureus can help clinicians make the best use of antimicrobial drugs and can also help with antimicrobial stewardship. The mechanisms and clinical implications of S. aureus defense systems, as well as potential response systems, were discussed in this study. Because resistance to all currently available antibiotics is unavoidable, new medicines are always being developed. Alternative techniques, such as anti-virulence and bacteriophage therapies, are being researched and may become major tools in the fight against staphylococcal infections in the future, in addition to the development of new small compounds that affect cell viability.

Citing Articles

Advances in antibacterial activity of zinc oxide nanoparticles against (Review).

Hao Y, Wang Y, Zhang L, Liu F, Jin Y, Long J Biomed Rep. 2024; 21(5):161.

PMID: 39268408 PMC: 11391181. DOI: 10.3892/br.2024.1849.

The application of CRISPR-Cas system in infection.

Wang J, Liu F, Long J, Jin Y, Chen S, Duan G Heliyon. 2024; 10(14):e34383.

PMID: 39108851 PMC: 11301371. DOI: 10.1016/j.heliyon.2024.e34383.

The Application of Rat Models in Infections.

Liang H, Wang Y, Liu F, Duan G, Long J, Jin Y Pathogens. 2024; 13(6).

PMID: 38921732 PMC: 11206676. DOI: 10.3390/pathogens13060434.

References

Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L . Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2010; 377(9761):228-41. DOI: 10.1016/S0140-6736(10)61458-4. View

Alnaseri H, Arsic B, Schneider J, Kaiser J, Scinocca Z, Heinrichs D . Inducible Expression of a Resistance-Nodulation-Division-Type Efflux Pump in Staphylococcus aureus Provides Resistance to Linoleic and Arachidonic Acids. J Bacteriol. 2015; 197(11):1893-905. PMC: 4420908. DOI: 10.1128/JB.02607-14. View

Bhattacharya M, Wozniak D, Stoodley P, Hall-Stoodley L . Prevention and treatment of Staphylococcus aureus biofilms. Expert Rev Anti Infect Ther. 2015; 13(12):1499-516. PMC: 5142822. DOI: 10.1586/14787210.2015.1100533. View

Boles B, Horswill A . Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 2008; 4(4):e1000052. PMC: 2329812. DOI: 10.1371/journal.ppat.1000052. View

Boles B, Horswill A . Staphylococcal biofilm disassembly. Trends Microbiol. 2011; 19(9):449-55. PMC: 3164736. DOI: 10.1016/j.tim.2011.06.004. View

Carvalhais V, Franca A, Cerca F, Vitorino R, Pier G, Vilanova M . Dormancy within Staphylococcus epidermidis biofilms: a transcriptomic analysis by RNA-seq. Appl Microbiol Biotechnol. 2014; 98(6):2585-96. DOI: 10.1007/s00253-014-5548-3. View

Cascioferro S, Carbone D, Parrino B, Pecoraro C, Giovannetti E, Cirrincione G . Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm-Associated Infections. ChemMedChem. 2020; 16(1):65-80. DOI: 10.1002/cmdc.202000677. View

Cascioferro S, Parrino B, Petri G, Cusimano M, Schillaci D, Di Sarno V . 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitors. Eur J Med Chem. 2019; 167:200-210. DOI: 10.1016/j.ejmech.2019.02.007. View

Clement S, Vaudaux P, Francois P, Schrenzel J, Huggler E, Kampf S . Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis. 2005; 192(6):1023-8. DOI: 10.1086/432735. View

10.

Conlon B . Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease. Bioessays. 2014; 36(10):991-6. DOI: 10.1002/bies.201400080. View

11.

Conlon B, Nakayasu E, Fleck L, LaFleur M, Isabella V, Coleman K . Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013; 503(7476):365-70. PMC: 4031760. DOI: 10.1038/nature12790. View

12.

Conlon B, Rowe S, Lewis K . Persister cells in biofilm associated infections. Adv Exp Med Biol. 2014; 831:1-9. DOI: 10.1007/978-3-319-09782-4_1. View

13.

Costa S, Mourato C, Viveiros M, Melo-Cristino J, Amaral L, Couto I . Description of plasmid pSM52, harbouring the gene for the Smr efflux pump, and its involvement in resistance to biocides in a meticillin-resistant Staphylococcus aureus strain. Int J Antimicrob Agents. 2013; 41(5):490-2. DOI: 10.1016/j.ijantimicag.2013.01.003. View

14.

Craigen B, Dashiff A, Kadouri D . The Use of Commercially Available Alpha-Amylase Compounds to Inhibit and Remove Staphylococcus aureus Biofilms. Open Microbiol J. 2011; 5:21-31. PMC: 3134978. DOI: 10.2174/1874285801105010021. View

15.

DeMarco C, Cushing L, Frempong-Manso E, Seo S, Jaravaza T, Kaatz G . Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2007; 51(9):3235-9. PMC: 2043220. DOI: 10.1128/AAC.00430-07. View

16.

Donlan R, Costerton J . Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15(2):167-93. PMC: 118068. DOI: 10.1128/CMR.15.2.167-193.2002. View

17.

Edwards A . Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol. 2012; 194(19):5404-12. PMC: 3457229. DOI: 10.1128/JB.00948-12. View

18.

Fisher R, Gollan B, Helaine S . Persistent bacterial infections and persister cells. Nat Rev Microbiol. 2017; 15(8):453-464. DOI: 10.1038/nrmicro.2017.42. View

19.

Floyd J, Smith K, Kumar S, Floyd J, Varela M . LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob Agents Chemother. 2010; 54(12):5406-12. PMC: 2981259. DOI: 10.1128/AAC.00580-10. View

20.

Foster T . Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev. 2017; 41(3):430-449. DOI: 10.1093/femsre/fux007. View